Literature DB >> 30711206

Refractory Celiac Disease.

Georgia Malamut1, Christophe Cellier2.   

Abstract

Refractory celiac disease (RCD) refers to persistence of malnutrition and intestinal villous atrophy for more than 1 to 2 years despite strict gluten-free diet in patients with celiac disease. Diagnosis remains difficult and impacts treatment and follow-up. RCD has been subdivided into 2 subgroups according to the normal (RCDI) or abnormal phenotype of intraepithelial lymphocytes (IELs) (RCDII). RCDII is considered as a low-grade intraepithelial lymphoma and has a poor prognosis due to gastrointestinal and extraintestinal dissemination of the abnormal IELs, and high risk of overt lymphoma.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cytokine IL-15; Enteropathy-associated T-cell lymphoma; Phenotype of intraepithelial lymphocytes; Refractory celiac disease

Mesh：

Substances：

Year:  2018        PMID： 30711206     DOI： 10.1016/j.gtc.2018.09.010

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN： 0889-8553            Impact factor:   3.806


  9 in total

1.  Updated guidelines by the European Society for the Study of Coeliac Disease.

Authors:  Alberto Rubio-Tapia; Joseph A Murray
Journal:  United European Gastroenterol J       Date:  2019-06-01       Impact factor: 4.623

Review 2.  Celiac Disease Revisited.

Authors:  João Calado; Mariana Verdelho Machado
Journal:  GE Port J Gastroenterol       Date:  2021-03-17

3.  Circulating microRNAs Suggest Networks Associated with Biological Functions in Aggressive Refractory Type 2 Celiac Disease.

Authors:  Nicoletta Bianchi; Luisa Doneda; Luca Elli; Cristian Taccioli; Valentina Vaira; Alice Scricciolo; Vincenza Lombardo; Anna Terrazzan; Patrizia Colapietro; Leonardo Terranova; Carlo Bergamini; Maurizio Vecchi; Lucia Scaramella; Nicoletta Nandi; Leda Roncoroni
Journal:  Biomedicines       Date:  2022-06-14

4.  Refractory Celiac Disease Type II: A Case Report and Literature Review.

Authors:  Richa Chibbar; Jordan Nostedt; Dana Mihalicz; Jean Deschenes; Ross McLean; Levinus A Dieleman
Journal:  Front Med (Lausanne)       Date:  2020-12-03

5.  Relationship between Persistent Gastrointestinal Symptoms and Duodenal Histological Findings after Adequate Gluten-Free Diet: A Gray Area of Celiac Disease Management in Adult Patients.

Authors:  Gloria Galli; Marilia Carabotti; Emanuela Pilozzi; Edith Lahner; Bruno Annibale; Laura Conti
Journal:  Nutrients       Date:  2021-02-12       Impact factor: 5.717

Review 6.  The Role of the Gluten-Free Diet in the Management of Seronegative Enteropathy.

Authors:  Anna Szaflarska-Popławska
Journal:  Nutrients       Date:  2021-11-11       Impact factor: 5.717

7.  Identification of a γc Receptor Antagonist That Prevents Reprogramming of Human Tissue-resident Cytotoxic T Cells by IL15 and IL21.

Authors:  Cezary Ciszewski; Valentina Discepolo; Alain Pacis; Nick Doerr; Olivier Tastet; Toufic Mayassi; Mariantonia Maglio; Asjad Basheer; Laith Q Al-Mawsawi; Peter H R Green; Renata Auricchio; Riccardo Troncone; Thomas A Waldmann; Nazli Azimi; Yutaka Tagaya; Luis B Barreiro; Bana Jabri
Journal:  Gastroenterology       Date:  2019-10-14       Impact factor: 22.682

8.  The Neuropathology of Gluten-Related Neurological Disorders: A Systematic Review.

Authors:  Maxine D Rouvroye; Panagiotis Zis; Anne-Marie Van Dam; Annemieke J M Rozemuller; Gerd Bouma; Marios Hadjivassiliou
Journal:  Nutrients       Date:  2020-03-20       Impact factor: 5.717

Review 9.  The Two Faces of Wheat.

Authors:  Herbert Wieser; Peter Koehler; Katharina A Scherf
Journal:  Front Nutr       Date:  2020-10-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.